Table 1.
Characteristics of study participants in the Atherosclerosis Risk in Communities Cohort, by the development of ESKD during 25 years of follow-up
| Characteristic | Overall | No ESKD | ESKD |
|---|---|---|---|
| N | 9650 | 9394 | 256 |
| Age, yr | 56.8 (5.7) | 56.8 (5.7) | 57.0 (5.5) |
| Black race, n (%) | 2330 (24.1) | 2193 (23.3) | 137 (53.5) |
| Female, n (%) | 5451 (56.5) | 5312 (56.5) | 139 (54.3) |
| Systolic BP, mm Hg | 121.0 (18.7) | 120.7 (18.3) | 133.3 (25.1) |
| Hypertension, n (%) | 3311 (34.5) | 3144 (33.6) | 167 (65.2) |
| Diabetes, n (%) | 1375 (14.3) | 1245 (13.3) | 130 (51.2) |
| NSAID use, n (%) | 4730 (49.1) | 4599 (49.1) | 131 (51.6) |
| Current smoker, n (%) | 2080 (21.6) | 2024 (21.6) | 56 (22.0) |
| Former smoker, n (%) | 3611 (37.5) | 3519 (37.5) | 92 (36.1) |
| eGFRcrcys (ml/min per 1.73 m2), mean (SD) | 98.3 (16.6) | 98.8 (15.9) | 82.3 (27.6) |
NSAID, nonsteroidal anti-inflammatory drug.